TERRI HALL: Open Payments
NPI 1891074282 · STAFFORDSVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 22 payments from 10 companies in 2025. Trend: 2023 $731 · 2024 $785 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| ABBVIE INC. | 1 | $32 |
| Dexcom, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Genmab U.S., Inc. | 1 | $14 |
Products named: LEQVIO, Kerendia, CAPLYTA, UBRELVY, Dexcom G6 Transmitter, TRINTELLIX, LIBTAYO, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
